PresentationIt's now my pleasure to turn the call over to John Fraunces, Director, Corporate Communications for LifeSci Advisors. Please go ahead, John.Good morning, and welcome to the VYNE Therapeutics conference call to discuss the merger of VYNE and Yarrow Bioscience. This call is being recorded for replay at the company's request.John FrauncesLifesci Advisors, LLC Good morning, and thank you for joining us for today's conference call. The link to this webcast is on the Investors page of the VYNE Therape ...